A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...

A clinic in Arapahoe County is exploring new ways to help patients by offering ketamine-assisted psychotherapy.

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...

A new study has found small amounts of liquid ketamine administered in a clinical setting can significantly reduce symptoms ...

A ketamine-derived nasal spray is now available for the millions of Americans living with severe depression. The ...

Respondents who said they used other drugs recreationally were also likelier to say they used ketamine during the past year ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used ...

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

Ketamine therapy has become known for its effects at combating depression and other mood disorders. There’s a growing body of ...

Spravato is now the first stand-alone therapy for treatment-resistant depression, for patients who haven't responded to oral ...

Because it is still awaiting approval, Medicare does not typically cover the use of ketamine infusion for treating mental ...

An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a ...